Canadian Solar (CSIQ) Continues Higher Following New Samsung Partnership
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Unusual 11 Mid-Day Movers 06/26: (RPTP) (RSOL) (HNSN) Higher; (MG) (MEET) (CBMX) Lower
June 26, 2013 2:17 PM EDTRaptor Pharmaceutical Corp. (Nasdaq: RPTP) 20.9% HIGHER; announced that the Office of Orphan Product Development at the Food and Drug Administration (FDA) granted Raptor orphan drug exclusivity for PROCYSBI (cysteamine bitartrate) delayed-release capsules for the management of nephropathic cystinosis patients age six and older. The exclusivity period began on the date of FDA approval, April 30, 2013, and lasts seven years subject to certain exceptions.
Real Goods Solar, Inc. (Nasdaq: RSOL) 18.8% HIGHER; has been selected by St. Albans Solar Partners,... More
